Drug Testing And Analysis 2012-01-01

Health status of ayahuasca users.

Paulo Cesar Ribeiro Barbosa, Suely Mizumoto, Michael P Bogenschutz, Rick J Strassman

Index: Drug Test. Anal. 4(7-8) , 601-9, (2012)

Full Text: HTML

Abstract

Ayahuasca is a psychedelic brew originally used for magico-religious purposes by Amerindian populations of the western Amazon Basin. Throughout the last four decades, the use of ayahuasca spread towards major cities in all regions of Brazil and abroad. This trend has raised concerns that regular use of this N,N-dimethyltryptamine- and harmala-alkaloid-containing tea may lead to mental and physical health problems associated typically with drug abuse. To further elucidate the mental and physical health of ayahuasca users, we conducted a literature search in the international medical PubMed database. Inclusion criteria were evaluation of any related effect of ayahuasca use that occurred after the resolution of acute effects of the brew. Fifteen publications were related to emotional, cognitive, and physical health of ayahuasca users. The accumulated data suggest that ayahuasca use is safe and may even be, under certain conditions, beneficial. However, methodological bias of the reviewed studies might have contributed to the preponderance of beneficial effects and to the few adverse effects reported. The data up to now do not appear to allow for definitive conclusions to be drawn on the effects of ayahuasca use on mental and physical health, but some studies point in the direction of beneficial effects. Additional studies are suggested to provide further clarification.Copyright © 2012 John Wiley & Sons, Ltd.


Related Compounds

  • Dimethyltryptamine

Related Articles:

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.

2016-01-22

[Toxicol. Lett. 241 , 82-94, (2015)]

Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases.

2014-04-01

[Biochem. Pharmacol. 88(3) , 393-401, (2014)]

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.

2012-01-01

[Drug Test. Anal. 4(7-8) , 610-6, (2012)]

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.

2011-09-01

[Biomed. Chromatogr. 25(9) , 970-84, (2011)]

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

2009-12-01

[J. Neural Transm. Gen. Sect. 116(12) , 1591-9, (2009)]

More Articles...